The Schazoo Pharmaceutical Laboratories (SPL) is currently the fastest growing Company in Pharmaceutical Market in Pakistan. Schazoo has been pursuing its vision “To provide Quality products at affordable prices to help nation to improve its quality of life” since 55 years. The company already has excellent product portfolio in ENT and Chest segment. To strengthen its ENT and Chest segment the company has launched a stupendous molecule Qflox (Gemifloxacin 320mg) to strengthen its Chest and ENT segment.
Qflox (Gemifloxacin 320mg) is a broad spectrum 4th generation fluoroquinolone. The Medical Professionals gave warm welcome to the product. Doctors appreciated the name of the product, superb and easy to remember. The affordable price of Qflox was another aspect which was very well supported by them.
Dr. Nisar Ahmad Rao, Assistant Professor of Agha khan University Hospital-Karachi spoke very high about Qflox by declaring it useful and effective addition in the treatment of united airways diseases. He further shared his clinical experience of using this advance generation of Quinolone in the effective management of COPD and community acquired pneumonia (CAP).
Dr. Zulkifal Awan, Assistant Professor of ENT-PIMS, Islamabad, presented his comments as “I have used Qflox (Gemifloxacin 320mg) in once daily dosage for seven days in cases of chronic SOM, Acute suppurative Otitis media and in cases of sinusitis he found it successful in more than 95% cases.
Dr. Muhammad Azam, Assis-tant Professor of Medicine Services Institute of Medical Sciences Lahore highlighted Qflox (Gemifloxacin 320mg) as an effective antibiotic for the treatment of lower respiratory tract infections.
Dr. Gul Muhammad, Chest Specialist & Member of Chest Society of Pakistan-Peshawar warmly welcome the product and said that Qflox (Gemifloxacin 320mg) is effective 4th generation Quinolone, very effective in CAP even in resistant cases as compared to ceftriaxone 2gm OD.
Dr. Muhammad Jawad Zaka-ud-Din Ghori, Chest Specialist-D.G. Khan shared his experience by saying that I am delighted to have a very healthy relationship with Schazoo pharmaceutical from last 6 years. The launch of Qflox (Gemifloxacin 320mg) has strengthened my believe that Schazoo Pharmaceutical is interested to launch molecules that are need of the day. Qflox (Gemifloxacin 320mg) has got excellent efficacy regarding AECB & CAP and I would love to use this medicine as a secret weapon to combat infections.
Dr. Farah Shafi, Associate Professor Services Institute Of Medical Sciences-Lahore said that Qflox (Gemifloxacin 320mg) is a new breed of Quinolones which seems to have bright future as it has shown good results in patients.
Dr. Humayoon Khan, Chest Specialist – Swat, declared Qflox (Gemifloxacin) as the drug of choice in LRTI now-a-day. He further said that the failure rate of this product is very low about 3-4% in community acquired pneumonia.
Dr. Muhammd Ayub Zahid, Chest & T.B. Specialist-Okara, used Qflox (Gemifloxcin 320mg) in his patients and get outstanding results. He said that Qflox (Gemifloxacin 320mg) has shown a magic response in my daily clinical practice, especially in treating Acute Exacerbation of Chronic Bronchitis and Community Acquired Pneumonia even in sever and resistant cases.
Dr. Afzal Memon, Sindh Govt Hospital Liaqatabad-Karachi preferred Qflox to treat his patients for maintaining their quality of life. He stated that no doubt Qflox (Gemifloxacin 320mg) is a revolutionized 4th generation quinolone in the field of microbiology covering a vide range of micro-organisms, especially in the field of chest medicine e.g. AECB & CAP.
Dr. Muhammad Faheem, E.N.T. & Allergy Specialist, Ex. Registrar of Nishtar Hospital-Multan shared his precious experience about Qflox (Gemifloxacin 320mg) by highlighting its very good results LRTI and also got very good results in the treatment of sinusitis.
Dr. Shahzad Khalid appre-ciated Schazoo Pharma-ceutical Laboratories (SPL) for providing quality products at affordable prices. He stated that Qflox(Gemifloxacin 320mg) has good efficacy and tolerance. Patient compliance is good and it is a good product available at an affordable price to the common man for the treatment of AECB & CAP.
Dr. Saif Ullah, from Lahore used Qflox (Gemifloxacin 320mg) in patients suffering from LRTI, AECB, CAP and found good results.
Such an overwhelming acceptance of Qflox by the leading specialists of Pakistan has added new dimensions in the overall motivation of Schazoo Pharmaceutical’s sales & marketing team. The new vigor and vitality has infused the passion to make Qflox a roaring success.